StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$99.25−5.59 (-5.33%)

Close on Nov 20, 2026Market cap $4.43BP/E –Yield –

Grail shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Grail's shares outstanding was 43M at Jun 30, 2026. For fiscal 2025 it was 37M, up 15.2% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202537M+15.2%
FY2024Dec 31, 202432M+2.7%
FY2023Dec 31, 202331M0.0%
FY2022Jan 1, 202331M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202643M+20.4%
Q1 FY2026Mar 31, 202641M+18.5%
Q4 FY2025Dec 31, 202541M+21.2%
Q3 FY2025Sep 30, 202536M+13.3%
Q2 FY2025Jun 30, 202536M+15.3%
Q1 FY2025Mar 31, 202534M+10.5%
Q4 FY2024Dec 31, 202434M+8.3%
Q3 FY2024Sep 30, 202432M+2.7%
Q2 FY2024Jun 30, 202431M0.0%
Q1 FY2024Mar 31, 202431M–
Q4 FY2023Dec 31, 202331M–
Q3 FY2023Oct 1, 202331M–
Q2 FY2023Jun 30, 202331M–

More Grail figures

See a number that looks wrong?